The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.10 (-6.06%)
Spread: 0.10 (6.667%)
Open: 1.65
High: 1.565
Low: 1.475
Prev. Close: 1.65
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

Mon, 27th Sep 2021 14:17

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

EMIS Group PLC - Leeds, England-based healthcare software company - Names Denise Collis as an additional independent non-executive director. Collis will formally join the board on Friday. Collis is currently non-executive director, chair of the remuneration committee and senior independent director at SThree PLC and non-executive director and chair of the remuneration committee at Smiths News PLC.

----------

Bank of Ireland Group PLC - Dublin-based company - Chief Financial Officer Myles O'Grady steps down to take up a senior finance role in an organisation outside the financial services sector. O'Grady is expected to leave BoI in March 2022 and a process to appoint his successor will now commence. Myles joined BoI in June 2019 as finance director Ireland and was appointed CFO in October 2019 and a member of the board in January 2020.

----------

Empiric Student Property PLC - London-based real estate investment trust - Says Martin Ratchford has been appointed as an independent non-executive director from Friday. Ratchford has held the post of CFO at Frasers Property UK Ltd since June 2018. Empiric also says Jim Prower will resign as a director on the same day as part of a planned succession process.

----------

Fuller, Smith & Turner PLC - London-based brewery - Says Finance Director Adam Councell will step down from his role and from the board on Thursday. Neil Smith will succeed Councell. In order to ensure a smooth handover to Smith, Councell has agreed to provide appropriate support to the business on a consultancy basis until Smith joins the business on November 30.

----------

Powerhouse Energy Group PLC - Bingley, England-based company which is transforming plastics and waste into clean energy - Says Non-Executive Director Allan Vlah will step down at the end of 2021 to concentrate on his other business interests. Powerhouse Energy appoints Keith Riley as a non-executive director with immediate effect. Riley is currently proprietor & chief executive officer of Vismundi Ltd, a consultancy company providing services to the resources and waste management industry.

----------

LSL Property Services PLC - Newcastle, England-based surveying services company - Names James Mack as a non-executive director, with immediate effect. Mack currently serves as CFO & executive director at Barclays Bank UK PLC. James was previously CFO & executive director at Aldermore PLC and Aldermore Group PLC.

----------

Aberdeen Asian Income Fund Ltd - Chelmsford, England-based investment firm - Hires Robert Kirkby as an independent non-executive director with effect from November 1. "Robert is a former advisory partner at KPMG Channel Islands and a fellow of the Institute of Chartered Accountants with a background as a business leader and a track record of establishing a business, growing revenue and building a dynamic team," says Chair Charles Clarke.

----------

Harland & Wolff Group Holdings PLC - Belfast, Northern Ireland-based investment company - Says Clive Richardson, non-executive chair, is stepping down from the board. Richardson's notice period will run until mid-December 2021. Richardson has decided to step down to focus on other activities to which he is already committed, Harland & Wolff says. A formal process to appoint a successor has been initiated and, whilst this progresses, Malcolm Groat, currently chair of the Audit Committee, has been named as interim chair.

----------

Shield Therapeutics PLC - Newcastle, England-based pharmaceutical company - Names Jose Menoyo as vice president & chief medical officer with immediate effect. Prior to joining Shield, Menoyo served as Head of US Medical Affairs at Alexion Pharmaceuticals Inc.

----------

Corcel PLC - London-based natural resource exploration and development company - Names Henry Bellingham as an independent non-executive director, subject the successful conclusion of due diligence procedures. "Henry has a wealth of experience in the natural resources arena, and I am delighted to welcome him to the team at such an exciting time for the business," says Chair James Parsons.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Sep 2022 20:43

EARNINGS SUMMARY: Open Orphan name change; Secured Income winds down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
1 Sep 2022 15:59

UK earnings, trading statements calendar - next 7 days

Friday 2 September 
Ashmore Group PLCFull Year Results
Monday 5 September 
Belvoir Group PLCHalf Year Results
Dechra Pharmaceuticals PLCFull Year Results
Tuesday 6 September 
Accrol Group Holdings PLCFull Year Results
Alumasc Group PLCFull Year Results
Ashtead Group PLCQ1 Results
Capricorn Energy PLCHalf Year Results
Gamma Communications PLCHalf Year Results
Headlam Group PLCHalf Year Results
Inspired PLCHalf Year Results
IQE PLCHalf Year Results
Lords Group Trading PLCHalf Year Results
Luceco PLCHalf Year Results
Michelmersh Brick Holdings PLCHalf Year Results
Midwich Group PLCHalf Year Results
NCC Group PLCFull Year Results
PCI-PAL PLCFull Year Results
Pebble Group PLCHalf Year Results
Quixant PLCHalf Year Results
STV Group PLCHalf Year Results
WAG Payment Solutions PLCHalf Year Results
WANdisco PLCHalf Year Results
Wednesday 7 September 
Bakkavor Group PLCHalf Year Results
Barratt Developments PLCFull Year Results
Equals Group PLCHalf Year Results
M Winkworth PLCHalf Year Results
Malin Corp PLCHalf Year Results
Petropavlovsk PLCHalf Year Results
Somero Enterprises IncHalf Year Results
Tissue Regenix Group PLCHalf Year Results
WH Smith PLCTrading Statement
Thursday 8 September 
Arecor Therapeutics PLCHalf Year Results
Cairn Homes PLCHalf Year Results
Curtis Banks Group PLCHalf Year Results
Darktrace PLCFull Year Results
Destiny Pharma PLCHalf Year Results
Duke Royalty LtdFull Year Results
Emis Group PLCHalf Year Results
Energean PLCHalf Year Results
Funding Circle Holdings PLCHalf Year Results
Genus PLCFull Year Results
International Public Partnerships LtdHalf Year Results
Melrose Industries PLCHalf Year Results
Mpac Group PLCHalf Year Results
Oakley Capital Investments LtdHalf Year Results
Open Orphan PLCHalf Year Results
Restaurant Group PLCHalf Year Results
Safestore Holdings PLCQ3 Results
Severfield PLCFull Year Results
Shield Therapeutics PLCHalf Year Results
SourceBio International PLCHalf Year Results
Spire Healthcare Group PLCHalf Year Results
Sylvania Platinum LtdFull Year Results
Vistry Group PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Aug 2022 19:38

IN BRIEF: Shield Therapeutics to gain USD10 million loan from AOP

Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Existing shareholder AOP Health International Management agrees to loan USD10 million to Shield, which will draw it down in a single tranche, and being secured over Shield's US intellectual property rights.

Read more
20 Jul 2022 16:03

UK shareholder meetings calendar - next 7 days

Thursday 21 July  
Big Yellow Group PLCAGM
Evgen Pharma PLCAGM
Experian PLCAGM
Halma PLCAGM
Intermediate Capital Group PLCAGM
Johnson Matthey PLCAGM
Octopus AIM VCT PLCAGM
Pennon Group PLCAGM
Pires Investments PLCGM re offer from Tern PLC
QinetiQ Group PLCAGM
SSE PLCAGM
Tern PLCGM re offer for Pires Investments PLC
Vp PLCAGM
Workspace Group PLCAGM
Zephyr Energy PLCAGM
Friday 22 July  
Chesterfield Resources PLCAGM
Homeserve PLCGM re offer by affiliates of Brookfield Infrastructure Partners LP
JD Sports Fashion PLCAGM
Landore Resources LtdAGM
President Energy PLCAGM
United Utilities Group PLCAGM
WANdisco PLCAGM
Monday 25 July 
BP Marsh & Partners PLCAGM
Keras Resources PLCAGM
Keras Resources PLCGM re share consolidation
Tuesday 26 July 
AO World PLCAGM
Bytes Technology Group PLCAGM
Dekel Agri-Vision PLCAGM
Firering Strategic Minerals PLCAGM
Mitie Group PLCAGM
Momentum Multi-Asset Value Trust PLCAGM
nanosynth group PLCAGM
NewRiver REIT PLCAGM
Ninety One PLC & LtdAGM
OnTheMarket PLCAGM
OptiBiotix Health PLCAGM
Telecom Plus PLCAGM
Vodafone Group PLCAGM
Xeros Technology Group PLCAGM
Wednesday 27 July 
Allied Minds PLCAGM
Caledonia Investments PLCAGM
De La Rue PLCAGM
FirstGroup PLCAGM
James Cropper PLCAGM
JPMorgan Japan Small Cap Growth & Income PLCAGM
Mode Global Holdings PLCAGM
Montanaro UK Smaller Cos Investment Trust PLCAGM
Motorpoint Group PLCAGM
Shield Therapeutics PLCAGM
Tatton Asset Management PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
14 Jul 2022 21:44

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Jun 2022 13:53

EARNINGS UPDATES: Kingswood revenue surges; Shield in loan deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
21 Mar 2022 14:38

TRADING UPDATES: Further progress at Blencowe and Rockfire mines

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
21 Mar 2022 11:58

Shield's Canadian partner files new drug submission for Accrufer

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that KYE Pharmaceuticals has submitted a new drug submission to Health Canada, for the regulatory review and approval of the iron therapy 'Accrufer'.

Read more
17 Feb 2022 15:51

Shield Therapeutics revenue falls in line with expectations

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported total 2021 revenue of £1.5m in a trading update on Thursday, in line with market expectations.

Read more
17 Feb 2022 11:54

Shield Therapeutics shares fall as guides for sharp 2021 revenue drop

(Alliance News) - Shield Therapeutics PLC's shares tumbled on Thursday after a trading update revealed a substantial, but expected, fall in revenue.

Read more
5 Jan 2022 13:43

Shield Therapeutics enters Accrufer licensing deal in Canada

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Wednesday, with KYE Pharmaceuticals in Canada.

Read more
5 Jan 2022 10:35

Shield Therapeutics signs license agreement in Canada for lead product

Shield Therapeutics signs license agreement in Canada for lead product

Read more
16 Dec 2021 15:21

Shield shares surge on expansion of US coverage for Accrufer

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on progress made on payer coverage of 'Accrufer' in the United States on Thursday.

Read more
16 Dec 2021 10:56

AIM WINNERS & LOSERS: Wressle boosts Europa Oil, Egdon and Union Jack

AIM WINNERS & LOSERS: Wressle boosts Europa Oil, Egdon and Union Jack

Read more
27 Sep 2021 14:26

Shield Therapeutics appoints chief medical officer

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that Dr Jose Menoyo is joining its senior executive team as vice-president and chief medical officer, with immediate effect.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.